Fact CheckerSign in

NCT06138223Recruiting

The Effect of exeRcise And Diet on Quality of Life in Patients With Incurable Cancer of Esophagus and Stomach (RADICES)

Source: ClinicalTrials.gov · Last updated 7 May 2026

Brief summary (registry, in English)

The survival of patients with incurable gastroesophageal cancer can extend over a year with anticancer therapy. However, the number of patients with deteriorating quality of life in this patient group steadily decreases over time during the treatment. Potentially reversible causes related to deterioration of quality of life are diminished muscle mass, physical capacity and nutritional status. Therefore, interventions that can target these in order to maintain or improve quality of life are urgently needed. However, it is yet unknown whether improvement of physical capacity and nutritional status improves quality of life in patients with incurable gastroesophageal adenocarcinoma after failure of first-line treatment. Since these patients are in a precarious situation, the benefits and harms of a combined exercise and nutritional intervention should be carefully evaluated.Therefore this study investigates the effect of a combined exercise and nutrition intervention compared to usual care on quality of life in incurable GAC patients after progression upon first-line treatment. A total of 196 patients with metastasized gastroesophageal cancer will be recruited and randomly allocated 1:1 to standard care or standard care plus a combined exercise and nutritional intervention.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
196 (estimated)
First submitted
2 Nov 2023
Start date
Jan 2024
Primary completion date
Sept 2028
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
NCT number
NCT06138223

What you commit to

  • Study type: Interventional
  • Planned participants: 196
  • From Jan 2024 to the primary completion date, Sept 2028
  • 22 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Pregnancy.
    • Note:
    • After one year of recruitment we broadened our inclusion criteria from GAC patients receiving beyond first-line palliative treatment or best supportive care to any patient with recurrence/progression of GAC after curative treatment or irresectable/metastatic disease at diagnosis, regardless of timing or type of palliative treatment and number of lines received. This was done to increase generalizability and offer the intervention earlier in the palliative phase to enhance its benefits. We acknowledge this results in a more heterogeneous group, but we believe also a more representative group.
    • The inclusion criterium before broadening was:
    • Progressive disease after first-line palliative systemic treatment OR within 6 months after completion of curative treatment (i.e. within six months after neoadjuvant chemoradiation, adjuvant nivolumab, or definitive chemoradiation for esophageal adenocarcinoma or within six months after adjuvant 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) for gastric/esophageal cancer or neoadjuvant FLOT if no adjuvant FLOT was given, or after progression during participation in the LyRICX study). Patients on capecitabine monotherapy who are eligible for oxaliplatin reintroduction can be included, too.

Other illness

  • Serious active infection.
  • Severe neurologic or cardiac impairment according to the American College of Sports Medicine criteria.
  • Uncontrolled severe respiratory insufficiency as determined by the treating clinician or if the patient is dependent on oxygen suppletion in rest or during exercise.

Other

  • Unstable bone metastases inducing skeletal fragility as determined by the treating clinician.
  • Untreated symptomatic known brain metastasis.
  • Too physically active (i.e. \>210 minutes/week of moderate-to-vigorous intentional exercise) or engaging in intense exercise training comparable to the RADICES exercise program.
  • Uncontrolled severe pain.
  • Any other contraindications for exercise as determined by the treating physician.
  • Any circumstances that would impede adherence to study requirements or ability to give informed consent, as determined by the treating clinician.

Who the study is looking for

  • Incurable adenocarcinoma of the esophagus or stomach
  • Recurrence after treatment with curative intent or irresectable/metastatic disease at primary diagnosis. Inclusion can take place regardless of the plan or the actual initiation of multi-line systemic treatment. (i.e. patients that have already started with anticancer therapy are eligible for inclusion too)\*
  • Able and willing to perform the exercise and nutritional program and wear the activity tracker.
  • Able and willing to fill out the POCOP/RADICES questionnaires.
  • Life expectancy \> 12 weeks.
  • Age ≥ 18 years.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (22)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Flevoziekenhuis
Coordinator of this site? Confirm its status
Almere StadNetherlandsRecruiting
Meander Medical Center
Coordinator of this site? Confirm its status
AmersfoortNetherlandsNot yet recruiting
Amsterdam UMC
Coordinator of this site? Confirm its status
AmsterdamNetherlandsRecruiting
Reinier de Graaf
Coordinator of this site? Confirm its status
DelftNetherlandsRecruiting
Catharina Ziekenhuis
Coordinator of this site? Confirm its status
EindhovenNetherlandsRecruiting
Beatrix Hospital
Coordinator of this site? Confirm its status
GorinchemNetherlandsRecruiting
Spaarne Gasthuis
Coordinator of this site? Confirm its status
HoofddorpNetherlandsRecruiting
Frisius Medical Center
Coordinator of this site? Confirm its status
LeeuwardenNetherlandsRecruiting
Leiden Universitair Medisch Centrum
Coordinator of this site? Confirm its status
LeidenNetherlandsRecruiting
Sint Antonius Hospital
Coordinator of this site? Confirm its status
NieuwegeinNetherlandsNot yet recruiting
Radboudumc
Coordinator of this site? Confirm its status
NijmegenNetherlandsRecruiting
Canisius Wilhelmina Ziekenhuis
Coordinator of this site? Confirm its status
NijmegenNetherlandsRecruiting
Laurentius Ziekenhuis
Coordinator of this site? Confirm its status
RoermondNetherlandsRecruiting
Bravis Ziekenhuis
Coordinator of this site? Confirm its status
RoosendaalNetherlandsRecruiting
Ikazia Ziekenhuis
Coordinator of this site? Confirm its status
RotterdamNetherlandsRecruiting
Erasmus Medical Center
Coordinator of this site? Confirm its status
RotterdamNetherlandsRecruiting
Jeroen Bosch Hospital
Coordinator of this site? Confirm its status
's-HertogenboschNetherlandsActive, not recruiting
HagaZiekenhuis
Coordinator of this site? Confirm its status
The HagueNetherlandsRecruiting
Elisabeth-TweeSteden Hospital
Coordinator of this site? Confirm its status
TilburgNetherlandsRecruiting
UMC Utrecht
Coordinator of this site? Confirm its status
UtrechtNetherlandsRecruiting
Diakonessenhuis
Coordinator of this site? Confirm its status
UtrechtNetherlandsNot yet recruiting
Zaans Medical Center
Coordinator of this site? Confirm its status
ZaandamNetherlandsRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.